Creative Planning’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Sell
93,492
-23,875
-20% -$75.6K ﹤0.01% 3546
2025
Q4
$434K Buy
117,367
+67,454
+135% +$218K ﹤0.01% 2957
2025
Q3
$132K Buy
+49,913
New +$96.5K ﹤0.01% 3620
2025
Q1
Sell
-34,989
Closed -$77K 3540
2024
Q4
$77K Buy
34,989
+11,756
+51% +$27.4K ﹤0.01% 3193
2024
Q3
$38.3K Buy
23,233
+2,636
+13% +$5.32K ﹤0.01% 3117
2024
Q2
$45.7K Buy
+20,597
New +$48.5K ﹤0.01% 2931
2023
Q4
Sell
-100
Closed -$98 2858
2023
Q3
$98 Buy
+100
New +$145 ﹤0.01% 2880
2020
Q1
Sell
-7,876
Closed -$470K 1934
2019
Q4
$470K Hold
7,876
﹤0.01% 1144
2019
Q3
$289K Sell
7,876
-235
-3% -$9.31K ﹤0.01% 1385
2019
Q2
$377K Sell
8,111
-19,493
-71% -$915K ﹤0.01% 1228
2019
Q1
$1.11M Buy
27,604
+19,755
+252% +$886K ﹤0.01% 688
2018
Q4
$361K Buy
7,849
+287
+4% +$13.8K ﹤0.01% 1128
2018
Q3
$336K Buy
7,562
+2,236
+42% +$103K ﹤0.01% 1327
2018
Q2
$209K Sell
5,326
-10,110
-65% -$511K ﹤0.01% 1620
2018
Q1
$1.12M Buy
15,436
+10,660
+223% +$783K ﹤0.01% 677
2017
Q4
$314K Buy
+4,776
New +$257K ﹤0.01% 1336
2017
Q3
Sell
-3,100
Closed -$143K 2434
2017
Q2
$143K Sell
3,100
-1
-0% -$37 ﹤0.01% 1725
2017
Q1
$109K Buy
+3,101
New +$71K ﹤0.01% 1895

Other funds holding ESPR